Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients

Background. Rifampicin is a pillar in the treatment of periprosthetic joint infection (PJI). However, rifampicin resistance is an increasing threat to PJI treatment. This study explores the incidence of rifampicin-resistant bacteria over time in a Swedish tertiary referral centre and the association...

Full description

Bibliographic Details
Main Authors: Stergios Lazarinis, Nils P. Hailer, Josef D. Järhult, Anders Brüggemann
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/10/1499